Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pain-Relief Medication-Parc de Salut Mar refers to a specific multi-modal analgesic regimen consisting of dexketoprofen, paracetamol, and tramadol. This combination is utilized as a standardized pain management protocol for patients undergoing surgical interventions for massive rotator cuff tears, specifically reverse shoulder prosthesis and arthroscopic decompression. Dexketoprofen is a non-steroidal anti-inflammatory drug (NSAID) that provides analgesia by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis. Paracetamol (acetaminophen) serves as a non-opioid analgesic and antipyretic with predominantly central effects. Tramadol is a centrally acting analgesic with a dual mechanism of action: it acts as a weak agonist at mu-opioid receptors and inhibits the neuronal reuptake of norepinephrine and serotonin. The combination of these three agents is designed to provide synergistic pain relief by targeting multiple physiological pathways involved in nociception and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexketoprofen + paracetamol + tramadol.